| Literature DB >> 19762282 |
Giuseppe Murdaca1, Paola Contini, Maurizio Setti, Paola Cagnati, Francesca Lantieri, Francesco Indiveri, Francesco Puppo.
Abstract
We have reported that serum level of soluble HLA-A, -B, -C (sHLA-A,-B,-C) antigens is elevated in HIV-infected subjects and decreases after antiretroviral therapy (HAART). In this study, we measured the levels of soluble HLA-G (sHLA-G) antigens in a cohort of HIV-infected patients before and during HAART. sHLA-G and sHLA-A, -B, -C levels were significantly elevated in HIV-infected subjects as compared with controls before antiretroviral treatment and significantly decreased after 36 months of HAART. sHLA-G levels were correlated with sHLA-A, -B, -C levels, the decrease of plasma HIV-RNA level, the increase of CD4+ T-lymphocyte number and the decrease of CD8+ T-lymphocyte number. These results suggest that the measurement of sHLA-G and sHLA-A, -B, -C antigen serum levels might represent a useful surrogate marker to monitor virological response and immune reconstitution in HIV-positive subjects undergoing HAART treatment.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19762282 DOI: 10.1016/j.clim.2009.08.002
Source DB: PubMed Journal: Clin Immunol ISSN: 1521-6616 Impact factor: 3.969